Dr. Frank Brodkey shares key insights from andexanet's development, approval, and real-world clinical trajectory.
The current kidney care model—focused on late-stage disease and in-center hemodialysis—is unsustainable, because of costs, environmental burden, poor outcomes, and reduced quality of life.
The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to ...
Universal Music Group N.V. ("UMG" or "the Company") today announced its financial results for the fourth quarter and full year ended December 31, 2025. "2025 was another standout year for UMG; ...
Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction, after getting a green light from the EMA's human medicine committee.
The global superstar celebrates the 2026 World Baseball Classic by gifting his national team a custom edition.
A federal judge has ruled Chris Gabehart can keep working at Spire Motorsports but only in a role unrelated to work he did as ...
AI-enhanced optical spectroscopy revolutionizes food quality monitoring with rapid, non-destructive analysis, ensuring safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results